Literature DB >> 21080872

Improved breast cancer biomarker detection through a simple, high frequency, low cost external proficiency testing program.

Tawny Hung1, Robert Wolber, John Garratt, Steven Kalloger, C Blake Gilks.   

Abstract

AIMS: We describe a simple, low cost, high frequency immunohistochemistry external proficiency testing program, and show how its use can lead to improved breast cancer biomarker detection.
METHODS: Over a 30 month period in British Columbia, Canada, we used tissue microarray slides to follow the performance of twelve clinical laboratories in nine separate external proficiency testing runs. Sensitivity for detection of oestrogen receptor (ER), progesterone receptor (PR), and HER2 were calculated for each laboratory, biomarker, and run.
RESULTS: Mean sensitivities for detection of ER, PR, and HER2 were 97.1%, 84.8%, and 90.7%, respectively. HER2 sensitivity improved over time, from 87.0% to 92.9% (p=0.04), with a trend towards improvement seen for PR (81.9-88.1%, p=0.13). ER sensitivities were high throughout the test period. Improvements occurred without mandating any specific laboratory changes.
CONCLUSIONS: This simple, low cost, high frequency external proficiency testing program is highly sustainable and can be implemented in any multi-institutional group or region.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080872     DOI: 10.3109/00313025.2010.520306

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  1 in total

1.  Comparison of the types of candidate reference samples for quality control of human epidermal growth factor receptor 2 status detection.

Authors:  Yulong Li; Rui Zhang; Yanxi Han; Tian Lu; Jiansheng Ding; Kuo Zhang; Guigao Lin; Jiehong Xie; Jinming Li
Journal:  Diagn Pathol       Date:  2016-09-10       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.